The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 654-662, September 2009

Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy

  • Francesco Onorati, MD

      Affiliations

    • Cardiac Surgery Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
    • Corresponding Author InformationAddress for reprints: Francesco Onorati, MD, Viale dei Pini, 28, 80131 Napoli, Italy.
  • ,
  • Antonino S. Rubino, MD

      Affiliations

    • Cardiac Surgery Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
  • ,
  • Domenico Marturano, MD

      Affiliations

    • Cardiac Surgery Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
  • ,
  • Eugenia Pasceri, MD

      Affiliations

    • Cardiology Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
  • ,
  • Giuseppe Santarpino, MD

      Affiliations

    • Cardiac Surgery Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
  • ,
  • Stefania Zinzi, MD

      Affiliations

    • Cardiology Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
  • ,
  • Giuseppina Mascaro, MD

      Affiliations

    • Cardiology Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy
  • ,
  • Attilio Renzulli, MD, PhD, FECTS

      Affiliations

    • Cardiac Surgery Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy

Received 16 October 2008; received in revised form 18 December 2008; accepted 24 January 2009. published online 09 April 2009.

Objective

Although mitral restrictive annuloplasty plus coronary artery bypass grafting are considered the best therapeutic strategies for ischemic cardiomyopathy with chronic mitral regurgitation, some recurrences are still reported. We evaluated predictors for late recurrence of ischemic cardiomyopathy with chronic mitral regurgitation.

Methods

Hospital outcome and serial clinical and echocardiographic (preoperative, discharge, 6 months, end of follow-up) follow-up assessments were recorded for 82 consecutive patients with ischemic cardiomyopathy with chronic mitral regurgitation having coronary artery bypass grafting + mitral restrictive annuloplasty (2 sizes ring downsizing). Recurrent ischemic cardiomyopathy with chronic mitral regurgitation was defined by grade ≥ 2 at echocardiography.

Results

Hospital mortality was 4.9%; 17.7 ± 1.7 (standard error) months (range 1–55) survival was 95.5% ± 2.5%. Two-year Kaplan-Meier freedom from reintervention was 94.2% ± 4.2%; from rerevascularization, 87.5% ± 11.7%; from congestive heart failure, 83.8% ± 5.7%; from ischemic cardiomyopathy with chronic mitral regurgitation grade ≥ 2, 46.5% ± 11.2%. Recurrence of ischemic cardiomyopathy with chronic mitral regurgitation gave lower 2-year Kaplan-Meier freedom from death (P = .03) and lower 2-year freedom from congestive heart failure (P = .0001), reintervention (P = .034), and tricuspid insufficiency (P = .0001). Ischemic cardiomyopathy with chronic mitral regurgitation recurrence correlated with worsened New York Heart Association class (P = .0001), left ventricular ejection fraction (P = .024), pulmonary arterial pressures (P = .0001), left ventricular end-diastolic diameter (P = .004), left ventricular end-systolic diameter (P = .014), indexed left ventricular mass (P = .008), and coaptation depth (P = .0001). Independent predictors for recurrent ischemic cardiomyopathy with chronic mitral regurgitation were previous anterior + posterior myocardial infarction (odds ratio 3.70; confidence interval 2.93–5.41; P = .001), preoperative left ventricular end-diastolic diameter ≥ 70 mm (odds ratio 3.91; confidence interval 2.65–5.22; P = .001), and coaptation depth at discharge ≥ 0.5 cm (odds ratio 11.9; confidence interval 5.91–21.34; P = .0001). Preoperative left ventricular end-diastolic diameter ≥ 70 mm correlated with higher congestive heart failure (P = .002), recurrent ischemic cardiomyopathy with chronic mitral regurgitation (P = .0001), worsened New York Heart Association class (P = .0001), and higher diuretics (P = .0001). Coaptation depth < 0.5 cm at discharge accounted for better survival (P = .010), lower incidence of congestive heart failure (P = .0001), lower need for diuretics (P = .0001), and improved New York Heart Association class (P = .0001).

Conclusions

Failure of mitral restrictive annuloplasty is responsible for follow-up mortality and congestive heart failure and correlates with absence of cardiac reverse remodeling. Prognosis of patients having mitral restrictive annuloplasty for ischemic cardiomyopathy with chronic mitral regurgitation is good, as long as a low postoperative coaptation depth is achieved. Patients with significant left ventricular dilation should be considered for different surgical strategies.

Abbreviations and Acronyms: AMI, acute myocardial infarction, CABG, coronary artery bypass grafting, CD, coaptation depth, CHF, congestive heart failure, CPB, cardiopulmonary bypass, ICMR, ischemic chronic mitral regurgitation, LAD, left atrial diameter, LVEDD, left ventricular end-diastolic diameter, LVEF, left ventricular ejection fraction, LVESD, left ventricular end-systolic diameter, LVMi, indexed left ventricular mass, mean Δp, transmitral mean gradient, MRA, mitral restrictive annuloplasty, MV, mitral valve, NYHA, New York Heart Association, PAP, systolic pulmonary arterial pressure, TI, tricuspid insufficiency grading

CTSNet classification: 18, 22, 23, 35

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5223(09)00156-1

doi:10.1016/j.jtcvs.2009.01.020

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 654-662, September 2009